PTC Therapeutics (PTCT) announced that the global Phase 2 placebo-controlled CardinALS study did not meet its primary endpoint of slowing ...
KAIST researchers have developed a groundbreaking single-atom editing technology using light-powered "molecular scissors" to ...
Researchers report development of an innovative intelligent light-guided biohybrid system, the CTPA/siCSF1R system, to target ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback